Brand family
Trelegy Ellipta
Fluticasone furoate, Umeclidinium and Vilanterol · GlaxoSmithKline
United States
- Presentations
- 2
- Markets
- 1
Trelegy Ellipta is a brand of Fluticasone furoate, Umeclidinium and Vilanterol marketed by GlaxoSmithKline, with 2 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Fluticasone furoate, Umeclidinium and Vilanterol
- Brand owner
- GlaxoSmithKline
- Registered in
- United States
- Strengths and forms
- 100 mcg/62.5 mcg/25 mcg inhalation powder, 200 mcg/62.5 mcg/25 mcg inhalation powder
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Trelegy Ellipta 100 mcg/62.5 mcg/25 mcg inhalation powderInhalation | GlaxoSmithKline | US FDA | Available on request |
| Trelegy Ellipta 200 mcg/62.5 mcg/25 mcg inhalation powderInhalation | GlaxoSmithKline | US FDA | Available on request |
Brand names and trademarks belong to their owners and are used only to identify products.
Request Trelegy Ellipta
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.